Plasma Protein Therapeutics Market 2021 Key Drivers and Challenges, Opportunities and Forecast Insights by 2026

News provided by

Shibuya Data Count

Jan 04, 2022, 00:56 EST

Shibuya-ku, Tokyo, Japan, Japan, Jan 04, 2022, 00:56 /Comserve / -- Plasma Protein Therapeutics Market is estimated to grow at the rate of 8.98% CAGR by 2027.

Plasma is the protein-rich fluid present in the blood, which has a vital role in clotting and providing immunity against diseases. They can be utilized in medical therapies, such as autoimmune, immune deficiencies, neurological and bleeding disorders when proteins are separated from plasma. By restoring the deficient or lost proteins in plasma, these protein therapies cure well-defined medical conditions. To treat life-threatening, chronic, and genetic diseases, plasma protein therapeutics are used, consisting of biological medicines, either infused or injected. The Plasma Protein Therapeutics Market is estimated to grow at the rate of 8.98% CAGR by 2027.

Download Sample PDF Of This Report:-

The key propellant factor for the plasma protein therapeutics market growth is the rising advents of new plasma-derived therapies. Further, the increasing number of life-threatening diseases such as immune or neurological systems and other diseases, including rabies, tetanus, hepatitis, A&B, and varicella, are the other key factors projected to compel the plasma protein therapeutics market growth. But, the restricted rules and regulations for handling plasma protein products are impeding the market growth.

Plasma Protein Therapeutics Market based on Type

• Coagulation Factors
• Immunoglobulins
• Albumins
• C1 esterase Inhibitors

Plasma Protein Therapeutics Market based on Application

• Hemophilia
• Primary Immunodeficiency Disorder
• Idiopathic Thrombocytopenic
• Purpura
• Secondary Immunodeficiency
• Hereditary Angioedema
• Others

Plasma Protein Therapeutics Market based on Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

As per the plasma protein therapeutics market by type, the market is divided into Coagulation Factors, Immunoglobulins, Albumins, and C1 esterase Inhibitors. Among them, the albumin segment is projected to obtain a significant share over the forecast period. This is driven by an enhanced diagnosis of hypoalbuminemia disease caused by liver cirrhosis and hepatitis B. Substantial demand and usage in China, which is the major market for albumin, is expected to boost the market growth further. Patients suffering from medium to severe hemophilia need clotting factor VIII as a preventive or on-demand therapy. The above factors are supporting the segment growth.

As in the plasma protein therapeutics market for application, the applications of the plasma protein therapeutics include Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic, Purpura, Secondary Immunodeficiency, Hereditary Angioedema, and Others. The hemophilia segment is anticipated to hold a substantial share in the market. The substantial share of this segment is attributed to the rising elderly population and the surging number of patients suffering from life-threatening diseases. Also, the shifting lifestyles, such as changing food habits and adopting sedentary lifestyles specifically in the urban areas, lead to diseases.

Further, the geographical plasma protein therapeutics market is categorized into North America, Europe, Asia Pacific, and the rest of the world. The North American region is placed at the top of the market share. This is due to the rising capital income, increasing modern technologies, and introduction of innovative therapies expected to drive the plasma protein therapeutics market growth in the region.

Quality and advancements in plasma therapeutics have been the favorable drivers of the global plasma protein therapeutics market to enhance patients' quality of life and assure donor safety. Plasma obtained through apheresis technology or complete blood donation procedure can either be gathered or bifurcated into plasma protein products which comprise one or more purified plasma protein or transferred directly to patients.

This report provides the few notable vendors of the plasma protein therapeutics market include Takeda Pharmaceutical Company Ltd., China Biologics Products Holdings, Bio Products Laboratory Ltd., ADMA Biologics, Inc., CSL Behring LLC, HEMA Biologics LLC, Biotest AG, Grifols S.A., Kedrion S.P.A., Inc., and Baxter International Ltd.

Download Sample PDF Of This Report:-

Hence, plasma protein has increased majorly in medical applications in the past few years. Along with the advancements in technology, the procedure of separating the protein from plasma has become highly cost-efficient and cost-saving, which has increased the importance of plasma protein therapies.

• This report offers an overall analysis of the present and future market trends and dynamics in the plasma protein therapeutics market.
• Geographically, the market report analyzes the regions such as North America, Europe, Asia Pacific, and the rest of the world.
• This report includes a comprehensive quantitative analysis of the present market and projections, which helps to identify the emerging market opportunities.
• This report also includes the significant plasma protein therapeutics market players and their dynamic strategies, expansions, mergers, acquisitions, and new product launches.

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Lauren Brown

Shibuya Data Count
Tel: + 81 50 50509159

Related Links

Also from this source

Calculators Market Size, Industry Share, In-depth Technology Analysis, Covers Global and Regional, Opportunities Forecast 2022-2031

The report predicts the global Calculators Market to grow at a healthy CAGR over the forecast period